Literature DB >> 10653858

IFN-gamma-independent IgG2a production in mice infected with viruses and parasites.

D Markine-Goriaynoff1, J T van der Logt, C Truyens, T D Nguyen, F W Heessen, G Bigaignon, Y Carlier, J P Coutelier.   

Abstract

After infection with some viruses and intracellular parasites, antibody production is restricted to IgG2a. We first observed that, whereas live viruses such as lactate dehydrogenase-elevating virus (LDV) or mouse adenovirus induced mostly an IgG2a response, a large proportion of antibodies produced against killed viruses were IgG1. This IgG1 antiviral response was suppressed when live virions were added to inactivated viral particles. These results indicate that the IgG2a preponderance is related to the infectious process itself rather than to the type of antigen involved. Since IFN-gamma is known to stimulate IgG2a production by activated B lymphocytes and to be secreted after infection, we examined the role of this cytokine in the antibody isotypic distribution caused by LDV. Most IgG2a responses were relatively unaffected in mice deficient for the IFN-gamma receptor or treated with anti-IFN-gamma antibody. A similar IFN-gamma-independent IgG2a secretion was observed after infection with the parasites Toxoplasma gondii and Trypanosoma cruzi. However, the IFN-gamma-independent IgG2a production triggered by infection still required the presence of functional T(h) lymphocytes. Therefore, signal(s) other than IFN-gamma secretion may explain the T(h)-dependent isotypic bias in antibody secretion triggered by viruses and parasites.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10653858     DOI: 10.1093/intimm/12.2.223

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  27 in total

1.  Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles.

Authors:  Daniel L Sprague; Bennett D Elzey; Scott A Crist; Thomas J Waldschmidt; Robert J Jensen; Timothy L Ratliff
Journal:  Blood       Date:  2008-01-15       Impact factor: 22.113

2.  Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.

Authors:  Jonathan Cenna; Gene S Tan; Amy B Papaneri; Bernhard Dietzschold; Matthias J Schnell; James P McGettigan
Journal:  Vaccine       Date:  2008-09-18       Impact factor: 3.641

3.  T-bet is required for protection against vaccinia virus infection.

Authors:  Masanori Matsui; Osamu Moriya; Takayuki Yoshimoto; Toshitaka Akatsuka
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

4.  Increased efficacy of the immunoglobulin G2a subclass in antibody-mediated protection against lactate dehydrogenase-elevating virus-induced polioencephalomyelitis revealed with switch mutants.

Authors:  Dominique Markine-Goriaynoff; Jean-Paul Coutelier
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  Effects on immunogenicity by formulations of emulsion-based adjuvants for malaria vaccines.

Authors:  Christopher B Fox; Susan L Baldwin; Thomas S Vedvick; Evelina Angov; Steven G Reed
Journal:  Clin Vaccine Immunol       Date:  2012-08-15

6.  A Single Locus Controls Interferon Gamma-Independent Antiretroviral Neutralizing Antibody Responses.

Authors:  Melissa Kane; Felicity Deiss; Alexander Chervonsky; Tatyana V Golovkina
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

7.  Anti-gamma interferon antibodies enhance the immunogenicity of recombinant adenovirus vectors.

Authors:  Shawn S Jackson; Jörn E Schmitz; Norman L Letvin
Journal:  Clin Vaccine Immunol       Date:  2011-09-07

8.  FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.

Authors:  Bolaji N Thomas; Laurence U Buxbaum
Journal:  Infect Immun       Date:  2007-12-10       Impact factor: 3.441

9.  Early-life co-administration of cockroach allergen and endotoxin augments pulmonary and systemic responses.

Authors:  K Kulhankova; C L S George; J N Kline; J M Snyder; M Darling; E H Field; P S Thorne
Journal:  Clin Exp Allergy       Date:  2009-04-28       Impact factor: 5.018

10.  Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin.

Authors:  Fu-Shi Quan; Yeu-Chun Kim; Dae-Goon Yoo; Richard W Compans; Mark R Prausnitz; Sang-Moo Kang
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.